Review Papers Claim by Claim

Executive scientific summary (visual-first, evidence‑linked)

• Thesis: The HIV capsid is not a passive container but a dynamic, cofactor-regulated machine that times reverse transcription (RT), nuclear import and uncoating to minimize innate sensing and target integration to favourable chromatin — thereby influencing transmission and pandemic potential Morling et al., J Gen Virol 2025 (review)
• Mechanistic pillars (as synthesized): intact capsids allow RT while protecting viral cDNA from cGAS/TREX1; sequential recruitment to FG pockets and the CypA loop provides directionality through the NPC; CPSF6 phase separation targets SPADs for integration; TREX1 degrades leaked DNA; Vpr/Vpx tune the post‑entry environment including SAMHD1 and HUSH (silencing) pathways Morling et al., key mechanistic synthesis

Critical appraisal — strengths

1. Comprehensive, current (to Jan 2025) integration of structural, biophysical and cell biology literature with mechanistic hypotheses that are falsifiable and testable Review integrates multi-modal evidence
2. Clear translational links (capsid as drug target: PF74, lenacapavir) and evolutionary perspective comparing pandemic vs non-pandemic lineages that sharpen testable claims about pandemicity.
3. Balanced discussion of accessory proteins (Vpr/Vpx) and of experimental caveats (cell model variability; Box 2) — increases trustworthiness.

Critical appraisal — key limitations & blindspots

• As a narrative review, it necessarily weights experiments unevenly; mechanistic claims (dynamic allostery hand‑off model) remain a high‑quality hypothesis but need direct in‑cell reconstitution/kinetic experiments for proof (authors acknowledge need for in situ structural work) Review notes experimental caveats
• Heavy reliance on primary‑cell in vitro assays (MDMs, MDDCs) and imaging — in vivo validation (animal models, patient samples) of the full sequential cofactor model is limited.
• Some mechanistic attributions (e.g., exact molecular pathway from CPSF6 phase separation to immune silence) are emerging fields and necessarily speculative at present; authors frame these carefully but readers must note uncertainty.

Where the review moves the field — practical takeaways

1. Capsid mechanics (stability/elasticity) are central: integrating AFM, MD and cryo‑ET data is a promising route to connect small molecule action (LEN) to capsid failure at the NPC.
2. Investigating cofactor stoichiometry and timing on authentic capsids in cells (live correlative cryo‑ET) is the primary experiment set that would validate/refute the sequential hand‑off model.
3. Comparative capsid sequence/structure work (pandemic M vs others) is a productive evolutionary approach to connect molecular adaptations to transmission phenotypes.

Short recommended experiments (visual)

Citations used (selective, for every major claim)

1. Morling et al., J Gen Virol (2025)

Interactive follow-ups

Run an AI scientist agent to (examples): map CA residue variation across M/O/2 lineages and predict cofactor‑binding changes; compute likely lenacapavir resistance pathways; design targeted mutations to test dynamic‑allostery model.